Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

KURAKURA
Showing 8 of 31 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in KURA ONCOLOGY INC

CITADEL ADVISORS LLC holds 328,105 shares of KURA (KURA ONCOLOGY INC), worth $3.6M as of 2026-Q2. The position was decreased (-11.0% shares). KURA represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$3.6M

Current Shares

328,105

Total Value Change

-$19.6M

Total Shares Change

-860,890

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
328,105
-11.0%
$3.6M0.0%$10.97
0
2026-Q1
Decreased
368,825
-5.6%
$3M0.0%$8.50
0
2025-Q4
Decreased
390,672
-51.7%
$4.1M0.0%$10.22
0
2025-Q3
Increased
808,818
+122.1%
$7.2M0.0%$8.97
44
2025-Q2
Decreased
364,155
-7.6%
$2.1M0.0%$5.67
0
2025-Q1
Decreased
394,241
-60.0%
$2.6M0.0%$7.05
0
2024-Q4
Decreased
986,951
-17.0%
$8.6M0.0%$8.51
0
2024-Q3
Increased
1.2M
+17.4%
$23.2M0.0%$19.52
33

Other major holders of KURA: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., Avoro Capital Advisors LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used